Industry Focus

Wildcard: Breaking Down CRISPR Technology

09.22.2021 - By The Motley FoolPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Tune in for Motley Fool Advisor Karl Thiel’s debut on Industry Focus as our resident biotech expert discusses the advances and challenges of CRISPR gene-editing technology, as well as how investors should be thinking about the space. Check out more of our content here: Podcasts Youtube Twitter Reach us by Email @ [email protected]

More episodes from Industry Focus